Infinity Pharmaceuticals Inc (OTCPK:INFIQ)
$ 0.0001 0 (0%) Market Cap: 9,000.00 Enterprise Value: -17.10 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Infinity Pharmaceuticals Inc at 2021 San Antonio Breast Cancer Symposium - Conference Call Transcript

Dec 10, 2021 / 02:30PM GMT
Release Date Price: $2.31 (-0.43%)
Operator

Good morning, everyone, and welcome to today's call, where we will review data updates from MARIO-3 from patients with PD-L1 positive and PD-L1 negative tumors in frontline metastatic triple-negative breast cancer. Participants on today's call are: Adelene Perkins, Chief Executive Officer; Dr. Robert Ilaria, Chief Medical Officer from Infinity Pharmaceuticals; and Dr. Hatem Soliman, Director of the Clinical Trials Unit at Moffitt Cancer Center.

During this call, we may make forward-looking statements about our future expectations and plans, including the clinical development objectives, the therapeutic potential of our product candidates, our strategic plans and financial projections. Our actual results may differ materially from what we project today due to a number of important factors, including the considerations described in the Risk Factors section of our annual and quarterly reports and in other filings we make with the SEC. These forward-looking statements represent our views only as of today. And we caution you that we may not update them in the future, whether as a result of new

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot